Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Murphy

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Cancer|June 15, 1981
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adultsB S Yap, R S Benjamin, M A Burgess, et al.
Cancer Treatment Reports|April 1, 1986
I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicityG Spitzer, M Valdivieso, P Farha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Primary chemotherapy of brain metastasis in small-cell lung cancerJ S Lee, W K Murphy, B S Glisson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1986
Neurotoxicity in long-term survivors of small cell lung cancerJ S Lee, T Umsawasdi, Y Y Lee, et al.
American Journal of Clinical Oncology|June 1, 1992
Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancerD M Shin, H M Dhingra, J S Lee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limitingD M Shin, P Y Holoye, W K Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancerH M Dhingra, M Valdivieso, D T Carr, et al.
Cancer|January 28, 1998
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinomaB Glisson, J S Lee, J Palmer, et al.
Cancer Research|June 1, 1975
Serial labeling index determination as a predictor of response in human solid tumorsW K Murphy, R B Livingston, V G Ruiz, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 6, 1998
Phase II trial of recombinant IFN-alpha2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancerF R Khuri, F V Fossella, J S Lee, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Cancer|June 15, 1981
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adultsB S Yap, R S Benjamin, M A Burgess, et al.
Cancer Treatment Reports|April 1, 1986
I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicityG Spitzer, M Valdivieso, P Farha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Primary chemotherapy of brain metastasis in small-cell lung cancerJ S Lee, W K Murphy, B S Glisson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1986
Neurotoxicity in long-term survivors of small cell lung cancerJ S Lee, T Umsawasdi, Y Y Lee, et al.
American Journal of Clinical Oncology|June 1, 1992
Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancerD M Shin, H M Dhingra, J S Lee, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limitingD M Shin, P Y Holoye, W K Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancerH M Dhingra, M Valdivieso, D T Carr, et al.
Cancer|January 28, 1998
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinomaB Glisson, J S Lee, J Palmer, et al.
Cancer Research|June 1, 1975
Serial labeling index determination as a predictor of response in human solid tumorsW K Murphy, R B Livingston, V G Ruiz, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 6, 1998
Phase II trial of recombinant IFN-alpha2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancerF R Khuri, F V Fossella, J S Lee, et al.
Pageof 7